Updated:
Flinn Foundation
The Flinn Foundation was established in 1965 by Dr. Robert S. Flinn, a prominent Phoenix cardiologist, and his wife Irene P. Flinn. Their bequest seeded a...
Flinn Foundation
The Flinn Foundation was established in 1965 by Dr. Robert S. Flinn, a prominent Phoenix cardiologist, and his wife Irene P. Flinn. Their bequest seeded a philanthropic endowment designed to improve the quality of life in Arizona, directly linking the foundation's investment portfolio to its grantmaking mission. The foundation operates from its headquarters and educational conference center on North Central Avenue in Phoenix. The foundation deploys capital through a flexible, multi-stage investment mandate that spans early-stage venture, distressed debt, secondaries, natural resources, and fund of funds commitments. Its portfolio construction combines direct startup investments with limited partner positions in external venture funds to cultivate Arizona's biotechnology and bioscience sectors. Mission-related investing anchors the strategy, with the foundation's partnership roles in the Arizona Bioindustry Association and the Greater Phoenix Economic Council shaping its deal pipeline. The endowment portfolio, estimated by Altss at approximately $244 million, underpins the foundation's programmatic work. Board Chair Eric Reiman, a noted Alzheimer's disease researcher, provides scientific and institutional leadership. The foundation strategically channels resources into affiliated initiatives, including joint administration of the Arizona Center for Civic Leadership with the Thomas R. Brown Family Private Foundation. The foundation's singular structural differentiator is the purposeful entanglement of its endowment returns with Arizona's statewide economic development agenda. Unlike typical private foundations that firewall investment management from program staff, Flinn's capital deployment strategy and its bioscience roadmap are coordinated with state economic bodies like the Arizona Commerce Authority to directly build the local innovation infrastructure.
General information
Firm type
Endowment / Foundation
Year founded
1965
Location
Region
North America
Country
United States
City
Phoenix
Corporate office
1802 N Central Ave, Phoenix, AZ 85004, United States
Principals
Tammy McLeod
President and CEO
Eric Reiman
Board Chair
Sector focus
Frequently asked questions
Who makes the final investment decisions at the Flinn Foundation?
The President and CEO, Tammy McLeod, oversees the foundation's operations and investment strategy. The Board of Directors, chaired by Alzheimer's researcher Eric Reiman, holds fiduciary responsibility for the endowment portfolio. Specific investment committee structures and the use of external consultants have not been publicly detailed by the foundation.
How does the Flinn Foundation's mission-driven mandate influence its portfolio construction?
The foundation's investment strategy is explicitly tied to advancing Arizona's bioscience sector. This mission alignment drives allocations into venture capital, natural resources, and distressed assets as tools for local economic development. The foundation collaborates with industry partners like the Arizona Bioindustry Association to source and shape these investments, blurring the traditional line between grantmaking and institutional investing.
Does the Flinn Foundation co-invest alongside venture capital firms or other family offices?
The foundation participates in fund of funds commitments and direct investments, serving as a limited partner in external venture vehicles. Its partnership with the Thomas R. Brown Family Private Foundation on the Arizona Center for Civic Leadership demonstrates a willingness to co-administer initiatives. However, specific co-investment structures alongside GPs in direct deals have not been disclosed.
What investment stages does the Flinn Foundation typically target?
The foundation deploys capital across the entire company lifecycle, from early-stage seed and startup funding through expansion and late-stage rounds. It also participates in distressed debt and secondaries transactions. This multi-stage approach provides a full-spectrum toolkit to catalyze bioscience company formation and growth in Arizona.
What is the Flinn Foundation's explicit policy on investing outside Arizona?
While the foundation's physical assets and primary mission focus on Arizona, its fund of funds investments may provide exposure to companies headquartered elsewhere. The foundation's direct investing and strategic collaborations are concentrated within North America, with no disclosed non-domestic deployment.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on endowments & foundations?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: